Welcome to CDC stacks | Doxycycline for post-exposure prophylaxis of anthrax : emergency use instructions for healthcare providers - 56836 | Stephen B. Thacker CDC Library collection
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All Simple Search
Advanced Search
Doxycycline for post-exposure prophylaxis of anthrax : emergency use instructions for healthcare providers
  • Published Date:
    08/18/2017
  • Language:
    English
Filetype[PDF-191.96 KB]


Details:
  • Description:
    Doxycycline EUI for Healthcare Providers (originally issued 03/28/2016; revised 08/18/2017)

    This fact sheet provides instructions for the use of doxycycline for post‐exposure prophylaxis (PEP) during an emergency involving anthrax (referred to as Emergency Use Instructions (EUI) fact sheet). Doxycycline is FDA‐approved for PEP of inhalation anthrax – to reduce the incidence or progression of disease following exposure to aerosolized Bacillus anthracis (B. anthracis). The Food and Drug Administration (FDA) has also issued an order permitting the emergency dispensing of oral formulations of doxycycline without a prescription during an anthrax emergency to individuals who may have been exposed to B. anthracis.

    doxy-eui-hcp-H.pdf

  • Main Document Checksum:
You May Also Like: